Participants in the trial must be between the ages of 18 and 50 and not diagnosed with HIV.  Moderna is set to start human trials for its experimental mRNA HIV vaccine as early as Thursday, the first time such a trial has ever been conducted. 

 

The big picture: “There’s a pressing need for new ways to prevent infection from viruses like HIV and influenza that conventional vaccines have struggled to address and to treat rare genetic diseases and cancers that kill millions each year,” Axios’ Alison Snyder writes. “Vaccines and therapies based on messenger RNA (mRNA) hold promise as a solution.”

 

Read the full article at: www.axios.com